TCMBANKIN005201 |
1,2,3,9-tetrahydropyrrolo(2,1-b)quinazolin-1-carboxylicacid |
|
C12H12N2O2 |
216.24 g/mol |
C1CC2=NC3=CC=CC=C3CN2C1C(=O)O |
TCMBANKIN006542 |
glucosyringicacid |
gluco-syringic acid; glucosyringic acid |
C15H20O10 |
360.31 g/mol |
COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)C(=O)O |
TCMBANKIN009632 |
benzyl alcoholβ-d-(2'-o-β-xylopyranosyl)glucopyranoside |
|
C18H26O10 |
|
C1C(C(C(C(O1)OC2C(C(C(OC2OCC3=CC=CC=C3)CO)O)O)O)O)O |
TCMBANKIN014225 |
Pedaliin |
2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; pedaliin; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone |
C22H22O12 |
478.4 |
COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC(=C(C=C3)O)O)O)OC4C(C(C(C(O4)CO)O)O)O |
TCMBANKIN015724 |
benzyl alcoholo-β-d-primveroside |
|
C18H26O10 |
|
|
TCMBANKIN016042 |
acetylpectolinarin |
|
C31H36O16 |
0 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(C(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)OC)OC(=O)C)OC)O)O)O)O)O)O |
TCMBANKIN022596 |
peganol |
|
C11H12N2O |
188.23 g/mol |
C1CC2=NC3=CC=CC=C3C(N2C1)O |
TCMBANKIN037356 |
Pedicularis-lactone-1-O-beta-D-glucoside |
pedicularis lactone-1-o-β-d-glucoside |
C15H22O9 |
346.33 |
[C@@]1([H])(C([H])([H])O[H])O[C@@]([H])(OC([H])([H])[C@]2([H])C(C([H])([H])O[H])=C([H])[C@]([H])(OC(=O)C3([H])[H])[C@@]23[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H] |
TCMBANKIN044887 |
7-hydroxy vasicine |
|
C11H12N2O2 |
204.22 g/mol |
C1CN2CC3=C(C=CC(=C3)O)N=C2C1O |
TCMBANKIN045101 |
pectolinarin |
NCGC00179136-01; SPBio_000199; I14-32401; KBioSS_001009; Spectrum2_000210; Spectrum3_000166; KBio3_001131; BG01193545; 5-HYDROXY-6-METHOXY-2-(4-METHOXYPHENYL)-7-{[(2R,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-({[(2R,3R,4R,5R,6S)-3,4,5-TRIHYDROXY-6-METHYLOXAN-2-YL]OXY}METHYL)OXAN-2-YL]OXY}CHROMEN-4-ONE; KBio2_003577; SR-05000002766; KBio2_006145; SPECTRUM200115; KBio1_001338; Spectrum4_001489; CCG-38413; 5-hydroxy-6-methoxy-2-(4-methoxyphenyl)-7-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one; SDCCGMLS-0066414.P001; ZINC3978447; AC1O8FH4; BSPBio_001631; SpecPlus_000298; Spectrum_000529; Spectrum5_000197; 4H-1-Benzopyran-4-one,7-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-5-hydroxy-6-methoxy-2-(4-methoxyphenyl)-; AKOS015909680; KBio2_001009; SR-05000002766-1; 978P021; BRD-K20043699-001-02-3; KBioGR_002097; CHEBI:109534; X1199; Pectolinarin; DivK1c_006394; 28978-02-1 |
C29H34O15 |
623 |
C1(c2c([H])c([H])c(OC([H])([H])[H])c([H])c2[H])=C([H])C(c3c(O1)c([H])c(O[C@]4([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[C@]5([H])O[C@@]([H])(C([H])([H])[H])[C@]([H])(O
[H])[C@@]([H])(O[H])[C@@]5([H])O[H])c(OC([H])([H])[H])c3O[H])=O |
TCMBANKIN058358 |
benzyl-D-glucopyranoside |
benzyl- D- glucopyrano- side;4304-12-5; TimTec1_005150; Benzyl .beta.-D-glucopyranoside; AIDS-186169; benzyl glucopyranoside; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(phenylmethoxy)tetrahydropyran-3,4,5-triol; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(phenylmethoxy)oxane-3,4,5-triol; AIDS186169; ACon1_002322; (2R,3R,4S,5S,6R)-2-(benzyloxy)-6-methylol-tetrahydropyran-3,4,5-triol;(2S,3S,4S,5S,6R)-2-(benzyloxy)-6-methylol-tetrahydropyran-3,4,5-triol; (2R,3S,4S,5S,6S)-2-(hydroxymethyl)-6-(phenylmethoxy)tetrahydropyran-3,4,5-triol; ST5309395; B5782_SIGMA;Benzyl glucopyranoside;benzyl alcoholo-β-d-glucopyranoside;Benzyl alpha-D-mannopyranoside |
C13H18O6 |
270.28 g/mol |
C1=CC=C(C=C1)COC2C(C(C(C(O2)CO)O)O)O |
TCMBANKIN058633 |
peganine |
vasicine |
C11H12N2O |
188.23 |
C1CN2CC3=CC=CC=C3N=C2C1O |
TCMBANKIN059859 |
3,5-dimethyl-4-methoxybenzoic acid |
|
C10H12O3 |
180.2 g/mol |
CC1=CC(=CC(=C1OC)C)C(=O)O |
TCMBANKIN061792 |
syringin |
C17H24O9; Glucoside, 4-(3-hydroxypropenyl)-2,6-dimethoxyphenyl, D; beta-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl; LS-172368; Ligustrin (VAN); NSC 287441;syringenone;Syrigin;cis-syringin;ligustrin |
C17H24O9 |
372.4 g/mol |
COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)C=CCO |
TCMBANKIN061793 |
liriodendrin |
HMS2205G05; syringaresinol diglucoside; liriodendrtachioside; MLS002472897; SMR001397008; NCGC00247452-01; Liriodendrin; CHEMBL505393; eleutheroside e |
C34H46O18 |
742.72 g/mol |
COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)C3C4COC(C4CO3)C5=CC(=C(C(=C5)OC)OC6C(C(C(C(O6)CO)O)O)O)OC |